Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
2,621
Views
4
CrossRef citations to date
0
Altmetric
Case Report

A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia

Yang Songa State Key Laboratory of Experimental Hematology, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Jiangxue Houa State Key Laboratory of Experimental Hematology, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Li Wana State Key Laboratory of Experimental Hematology, Tianjin, People’s Republic of ChinaView further author information
,
Kaiqi Liub National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
,
Chunlin Zhoub National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Shuning Weib National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Guangji Zhangb National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Dong Linb National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Yan Lib National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Qiuyun Fangb National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Yuntao Liub National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Benfa Gongb National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Xiaoyuan Gongb National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Ying Wangb National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Hui Weia State Key Laboratory of Experimental Hematology, Tianjin, People’s Republic of China;b National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
,
Jianxiang Wanga State Key Laboratory of Experimental Hematology, Tianjin, People’s Republic of China;b National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaView further author information
&
Yingchang Mia State Key Laboratory of Experimental Hematology, Tianjin, People’s Republic of China;b National Clinical Research Center for Blood Diseases, Tianjin, People’s Republic of China;c Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People’s Republic of ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
 show all
Pages 518-522 | Published online: 11 May 2022

References

  • Grimwade D, Lo Coco F. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia. Leukemia. 2002;16(10):1959–1973.
  • Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152.
  • Conserva MR, Redavid I, Anelli L, et al. RARG gene dysregulation in acute myeloid leukemia. Front Mol Biosci. 2019;6:114.
  • Zhang X, Sun J, Yu W, et al. Current views on the genetic landscape and management of variant acute promyelocytic leukemia. Biomark Res. 2021;9(1):33.
  • Shiba N, Yoshida K, Hara Y, et al. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. Blood Adv. 2019;3(20):3157–3169.
  • Osumi T, Tsujimoto SI, Tamura M, et al. Recurrent RARB translocations in acute promyelocytic leukemia lacking RARA translocation. Cancer Res. 2018;78(16):4452–4458.
  • Geoffroy MC, de The H. Classic and variants APLs, as viewed from a therapy response. Cancers. 2020;12(4):967.
  • Qin YZ, Huang XJ, Zhu HH. Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia. Leukemia. 2018;32(10):2285–2287.
  • Such E, Cervera J, Valencia A, et al. A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia. Blood. 2011;117(1):242–245.
  • Zhang X, Li F, Wang J, et al. RARgamma-rearrangements resemble acute promyelocytic leukemia and benefit from 3 + 7 regimen. Leuk Lymphoma. 2019;60(7):1831–1834.
  • Su Z, Liu X, Xu Y, et al. Novel reciprocal fusion genes involving HNRNPC and RARG in acute promyelocytic leukemia lacking RARA rearrangement. Haematologica. 2020;105(7):e376-e8.
  • Ha JS, Do YR, Ki CS, et al. Identification of a novel PML-RARG fusion in acute promyelocytic leukemia. Leukemia. 2017;31(9):1992–1995.
  • Wen L, Xu Y, Yao L, et al. Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions. Haematologica. 2019;104(5):e195–e1e9.
  • Han SP, Tang YH, Smith R. Functional diversity of the hnRNPs: past, present and perspectives. Biochem J. 2010;430(3):379–392.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.